Review
Aug 2026
Advances in nucleotide-based P2Y₁ antagonism: implications for cardiovascular therapeutics.
Advances in P2Y₁R signaling, pharmacology, and structure-based design are integrated, emphasizing the evolution of nucleotide antagonists and their translational potential, and insights establish P2Y₁R antagonism as a promising strategy for next-generation cardiovascular therapeutics.
N. Erathodiyil, V. Raveendran, Jackie Y. Ying
· Medicinal Chemistry Research · 0 citations